{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-001738","form_type":"8-K","ticker":"SLSN","cik":"0000883107","company_name":"SOLESENCE, INC.","filed_at":"2025-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.657687+00:00","generated_at":"2026-05-24T05:22:50.382991+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Solésence reports record full-year 2024 revenue of $52.3M, net income of $4.2M vs loss in 2023","bullets":["Q4 revenue $12.6M (+57.5% YoY); gross profit $2.8M (22% margin) vs $0.5M (6%) in Q4 2023.","FY 2024 revenue $52.3M (+40% YoY); net income $4.2M vs net loss $4.4M in FY 2023.","Company rebranded as Solésence; plans to pursue NASDAQ uplisting and search for dedicated CFO in 2025.","Initiated expanded batch-making capacity at Bolingbrook facility to support over $200M annual revenue.","Launched over two dozen new SKUs in prestige and mass beauty; Au Lait Face Milk SPF 50+ won C&T Allē Award."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-001738","json":"https://secwatch.observer/filing/0001171843-25-001738.json","markdown":"https://secwatch.observer/filing/0001171843-25-001738.md","text":"https://secwatch.observer/filing/0001171843-25-001738.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883107/000117184325001738/0001171843-25-001738-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883107/000117184325001738/f8k_032625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T05:22:50.382991+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}